职位

Vir Biotechnology

VI

Vir Biotechnology

Immunology-focused biotech

Drug Discovery

Immunology

Infectious Diseases

Clinical Research

Bioinformatics

San Francisco, California

201-500

2016年成立(第10年)

混合办公

Public

估值

$1.2B

融资总额

$700M

VIR

$9.78

Vir Biotechnology在招职位

3个在招职位

Senior Manager, Quality Control

工程

San Francisco, California, United States

现场办公

资深

全职

Learning Budget

401k

绩效奖金

通勤补贴

Senior Director, Clinical Research-Infectious Disease

机器学习

San Francisco, California, United States

现场办公

总监级

全职

Learning Budget

401k

绩效奖金

通勤补贴

Associate Director, Clinical Transactional Counsel

医疗/健康科技

San Francisco, California, United States

现场办公

总监级

全职

Learning Budget

401k

绩效奖金

通勤补贴

已关闭职位

50个职位

Scientist, In Vivo (Temporary)

San Francisco, California, United States

中级

已关闭 3天前

Principal Regulatory Writer (Temporary)

Remote - United States

Staff+

已关闭 4天前

Regulatory Writer and/or Regulatory QC/ Editor (Temporary)

Remote - United States

中级

已关闭 5天前

Senior Regulatory Writer (Temporary)

Remote - United States

资深

已关闭 6天前

Senior Director, Clinical Research-Oncology

San Francisco, California, United States

总监级

已关闭 1周前

产品与服务

Tobevibart and Elebsiran Combination Therapy for Chronic Hepatitis Delta

Tobevibart and Elebsiran Combination Therapy for Chronic Hepatitis Delta

Antiviral Therapeutics

VI

VIR-2218

Antiviral Therapy

VI

VIR-3434

Monoclonal Antibody

VI

VIR-7831 (Sotrovimab)

Monoclonal Antibody

EL

Elebsiran (VIR-2218)

Antiviral Therapy

PRO-XTEN™ Masked T-cell Engagers for Oncology

PRO-XTEN™ Masked T-cell Engagers for Oncology

Immuno-Oncology

PL

Platform Technologies

Technology Platform

CO

COVID-19 Variant Antibodies

Monoclonal Antibody

SO

Sotrovimab

Antiviral Therapy

HI

HIV Cure Research

Antiviral Therapy

VI

VIR-7229

Antiviral Therapy

MA

Malaria Prevention Program

Monoclonal Antibody

VI

VIR-2482

Antiviral Therapy

VI

VIR-1111

T Cell Immunotherapy

TO

Tobevibart (VIR-3733)

Antiviral Therapy

T

T Cell Platform

Platform Technology

CO

COVID-19 Antibody Program

Antiviral Therapy

领导团队

LP

Louis Picker

Co-Founder

KF

Klaus Frueh

Co-Founder

RN

Robert Nelsen

Co-Founder

SR

Steven Rice

Chief Administrative Officer

浏览量

91

申请点击

0

模拟申请

0

收藏

0

评价

3.7

10条评价

工作生活平衡

3.2

薪酬

2.8

企业文化

4.1

职业发展

3.8

管理层

3.0

65%

推荐率

优点

Supportive and collaborative team culture

Cutting-edge research and meaningful work

Professional development opportunities

缺点

Heavy workload and frequent overtime

Management lacks clear direction and communication

Fast-paced and high-pressure environment

薪资范围

22个数据点

Junior/L3

1份报告

-

年薪总额

基本工资

$135,000

股票

-

联系方式与地址